Revolymer announced that it will appoint Dr. Louise Crascall as Chief Commercial Officer with effect from 1 June 2016. Dr. Crascall has 20 years of experience in technical and commercial roles in the specialty chemicals industry and will bring significant commercial expertise, along with a broad technical understanding, to augment Revolymer's management team. Dr. Crascall will join Revolymer from Vivimed Labs Europe Ltd, where she has served as Commercial Operations Director and Chief Marketing Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
162 GBX | 0.00% | -3.28% | +36.13% |
May. 20 | Itaconix shares rise on new orders and regulatory approvals | AN |
Apr. 29 | Itaconix launches two new plant-based ingredients for detergents | AN |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+36.13% | 27.8M | |
+20.38% | 68.19B | |
-0.77% | 48.31B | |
+25.06% | 44.85B | |
+32.28% | 28.6B | |
+7.64% | 19.05B | |
+11.25% | 16.53B | |
-6.71% | 15.83B | |
-23.40% | 15.49B | |
-21.05% | 13.41B |
- Stock Market
- Equities
- REVO Stock
- News Itaconix plc
- Revolymer Announces to Appoint Louise Crascall as Chief Commercial Office, Effective June 1, 2016